Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Curcuma wenyujin root aqueous extract is a traditional Chinese medicine (TCM) preparation derived from the roots of *Curcuma wenyujin*, a plant in the Zingiberaceae (ginger) family. This natural product extract is a complex mixture containing approximately 169 bioactive compounds, including β-elemene, curcumenol, and various sesquiterpenoids. Preclinical research indicates that the extract exerts neuroprotective effects in Alzheimer's disease models by modulating the PI3K/Akt/GSK-3β signaling pathway and reducing tau protein phosphorylation. It also demonstrates vascular endothelial protection against lipopolysaccharide (LPS)-induced damage by inhibiting the TLR4 signaling pathway and reducing the expression of matrix metalloproteinases MMP2 and MMP9. Beyond neuroprotection and vascular health, the extract has shown anti-inflammatory, antitumor, antioxidant, and hepatoprotective properties in academic studies. It is currently utilized as a research compound and is not yet a commercially developed pharmaceutical product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on curcuma wenyujin root aqueous extract.